• SENSEX 74,902.57
    373.49 (+0.50%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Meesho
    230.80 125.70(%)
  • Allied Blenders
    667.75 719.95(%)
  • Escorts Kubota
    2,828.00 3,998.95(%)
  • Molbio Diagnosti
    1,338.00 1,686.50(%)
  • Swiggy
    279.80 235.85(%)
  • Ather Energy
    1,484.00 535.00(%)
  • Kanohar Elect.
    938.00 905.50(%)
  • Ola Electric
    42.32 59.20(%)
  • Tour. Fin. Corp.
    143.00 148.00(%)
  • Glass Wall Syst.
    296.00 185.05(%)
  • HDFC Bank
    742.80 1,020.35(%)
  • Cupid
    268.35 298.95(%)
  • Eternal
    344.75 368.40(%)
  • PC Jeweller
    14.87 14.45(%)
  • Elecon Engg.Co
    476.90 628.45(%)
  • Solar Industries
    20,362.20 22,630.05(%)
  • Cholaman.Inv.&Fn
    1,783.85 1,952.00(%)
  • Wockhardt
    2,359.60 2,420.00(%)
  • IDFC First Bank
    89.58 88.70(%)
  • Bluestone Jewel
    845.35 400.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Hikal Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Kalyani
  • BSE Code : 4401.0
  • ISIN : INE475B01022
227.00 -2 (-0.94%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    225.20

  • Today’s High

    234.00

  • Open

    229.50

  • Perv Close

    229.15

  • 52W Low

    146.25

  • 52W High

    282.70

Key Indicators

  • P/E(TTM)

    65.85

  • Mar.Cap (₹Cr.)

    2,798.93

  • Div & Yield %

    0.26

  • Book Value(₹)

    97.24

  • Debt-Equity Ratio

    -0.94

  • AGM Date

    22-Sep-2026

  • EPS

    3.46

  • P/E Ratio

    65.85

Financials Ratios

  • Debt-Equity Ratio

    0.67

  • Mar.Cap (₹Cr.)

    2,798.93

  • RONW (%)

    6.00

  • ROCE (%)

    7.51

Score Board

  • Equity (₹ in Cr.)

    24.66

  • BV (₹)

    97.20

  • Sales( ₹ in Cr.)

    1,712.60

  • NP (in Cr.)

    27.30

  • NP Var(%)

    -70.0

  • Div%

    30.0

  • CPS (₹)

    15.50

  • EPS (₹)

    2.20

  • Traded Value (₹ in Lakhs)

    2,809.41

  • 52 Week High

    282.70

  • 52 Week Low

    146.25

  • Price BSE

    228.0

  • Price NSE

    227.00

  • Market Capital( in Cr.)

    2,809.41

  • P/C Ratio

    14.70

  • P/E Ratio

    103.00

  • Price Vs.BV

    2.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,712.60 1,859.80 1,784.60 2,023.03 1,942.72 1,720.44
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,712.60 1,859.80 1,784.60 2,023.03 1,942.72 1,720.44
Other Income 12.30 5.00 2.50 5.41 4.89 4.98
Stock Adjustments 36.90 45.30 -19.50 14.56 35.82 -1.67
Total Income 1,761.80 1,910.10 1,767.60 2,043.00 1,983.43 1,723.75
EXPENDITURE :            
Raw Materials 798.60 882.60 805.20 1,121.59 1,032.21 906.71
Power and Fuel Cost 169.80 168.10 170.20 186.91 175.46 147.83
Employee Cost 266.00 242.30 244.00 220.40 201.35 164.32
Other Manufacturing Expenses 132.40 141.50 136.50 114.60 106.37 91.27
Selling and Administration Expenses 130.00 115.20 116.20 110.01 101.31 64.05
Miscellaneous Expenses 117.30 26.90 26.10 27.02 21.28 21.71
Employee Benefit Expenses 266.00 242.30 244.00 220.40 201.35 164.32
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,614.10 1,576.60 1,498.20 1,780.53 1,637.98 1,395.88
Operating Profit 147.70 333.50 269.40 262.47 345.46 327.87
Interest 62.10 75.20 56.40 48.10 31.22 36.20
Gross Profit 85.60 258.30 213.00 214.37 314.24 291.67
Depreciation 163.80 134.40 117.60 109.01 95.67 85.25
Profit Before Tax -78.20 123.90 95.40 105.36 218.57 206.42
Current Tax -2.00 30.00 28.40 30.48 59.65 79.55
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -27.50 3.00 -2.50 -3.49 -1.59 -6.27
Reported Net Profit -48.70 90.90 69.50 78.38 160.51 133.14
Extraordinary Items -76.00 0.63 0.42 0.45 0.14 0.01
Adjusted Net Profit 27.30 90.27 69.08 77.93 160.37 133.13
Adjustment below Net Profit -2.20 -1.40 -0.70 -0.60 1.19 -1.44
P & L Balance brought forward 998.60 924.00 870.00 804.60 670.03 553.12
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 12.30 14.90 14.80 12.33 27.13 14.80
P & L Balance carried down 935.40 998.60 924.00 870.05 804.60 670.03
Dividend 2.40 0.00 0.00 0.00 0.00 12.33
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 70.00 60.00 60.00 80.00 100.00
Dividend Per Share(Rs) 0.60 1.40 1.20 1.20 1.60 2.00
Earnings Per Share-Unit Curr -3.94 7.36 5.63 6.36 13.02 10.80
Earnings Per Share(Adj)-Unit Curr -3.94 7.36 5.63 6.36 13.02 10.80
Book Value 97.09 102.20 96.16 91.93 86.62 75.70
Book Value(Adj)-Unit Curr 97.09 102.20 96.16 91.93 86.62 75.70

Shareholding Pattern

  • Promoter Group

    68.85%

  • Public Share Holding

    31.15%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 72,172,664 58.53 72,172,664 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,082,600 9.80 12,082,600 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 637,500 0.52 637,500 7
Others 0 0.00 0 0
Sub Total 84,892,764 68.85 84,892,764 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 250 0.00 250 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,218,569 0.99 1,218,569 32
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 7,301,726 5.92 7,301,726 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,619,232 1.31 1,619,232 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,139,777 8.22 10,139,777 41
2] Non Institution
Bodies Corporate 1,551,327 1.26 1,551,327 262
Clearing Members 83,346 0.07 83,346 30
Directors of their Relatives 450,976 0.37 450,976 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,195,728 1.78 2,195,728 1,482
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,318,542 1.07 1,318,542 1,436
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,299,482 1.86 2,299,482 8
Individuals holding nominal share capital up to Rs. 1 lakh 19,693,725 15.97 19,584,450 70,196
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18,515 0.02 18,515 2
Others 420,653 0.34 420,653 6
Sub Total 28,268,209 22.93 28,158,934 73,469
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 123,300,750 100.00 123,191,475 73,527

Company Background

Hikal LtdPharmaceuticals - Indian - Bulk Drugs

  • Hikal Ltd
  • BSE Code : 4401.0
  • ISIN : INE475B01022

  • Incorporation Year

    1988

  • Registered Office

    717/718 Maker Chamber V
    7th Floor Nariman Point, Mumbai,
    Maharashtra-400021

  • Telephone

    91-022-3926 7100/62770477

  • FAX

    91-022-2283 3913

  • Chairman

    J Hiremath

  • Managing Director

  • Company Secretary

    Rajasekhar Reddy

  • Auditor

    S R B C & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Hikal Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Hikal 227.85 1,724.90 1,712.60 -83.77 3.35
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77